Clinical Trial Update: 18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 18F-Fluoro-L-DOPA PET imaging to detect and localize focal congenital hyperinsulinism; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hyperinsulinism

Drugs mentioned

• 18F-Fluoro-L-DOPA (fluorodopa radiotracer)

Snippet

Sponsor: Miguel Pampaloni | Conditions: Congenital Hyperinsulinism | Phase 2 | Status: RECRUITING